RBC Bioscience Corporation (TPEX:6848)
Taiwan · Delayed Price · Currency is TWD 19.60
+0.25 (1.29%)
Jul 22, 2026, 12:49 PM CST
RBC Bioscience Company Description
RBC Bioscience Corporation manufactures and sells reagents and devices for life science and molecular diagnosis.
It offers robotic bench-top workstation for nucleic acid purification under the MagCore Plus II and Giga Automated Nucleic Acid Extractor names; MagCore Super Automated Nucleic Acid Extractor, an automated workstation for nucleic acid extraction; and MagCore EDA Automatic Extraction and Smart PCR Setup, an instrument for nucleic acid extraction and PCR setup pre-treatment.
The company also provides NGS, genomic DNA, viral nucleic acids, and total RNA kits. It has operations in Taiwan, rest of Asia, Africa, the United States, and internationally.
RBC Bioscience Corporation was founded in 1995 and is based in New Taipei City, Taiwan.
RBC Bioscience Corporation
| Country | Taiwan |
| Founded | 1995 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 50 |
| CEO | Mingwei Zhuo |
Contact Details
Address: No. 15, Qiaohe Road New Taipei City, 235029 Taiwan | |
| Phone | 886 2 8912 1200 |
| Website | rbcbioscience.com |
Stock Details
| Ticker Symbol | 6848 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006848005 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Mingwei Zhuo | Chairman and GM |
| Sulan Fang | Accountant and Accounting Supervisor |
| Yen-Liang Chen | Deputy General Manager of Manufacturing Department |
| Kexin Zhan | Deputy General Manager of Management Office |
| Zhengwei Wei | Director of Research & Development |